National Guideline Clearinghouse | Sorafenib for the treatment of advanced hepatocellular carcinoma.

Guideline Title
Sorafenib for the treatment of advanced hepatocellular carcinoma.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Sorafenib for the treatment of advanced hepatocellular carcinoma. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 May. 34 p. (Technology appraisal guidance; no. 189).


Guideline Status
This is the current release of the guideline.


full-text:
National Guideline Clearinghouse | Sorafenib for the treatment of advanced hepatocellular carcinoma.